Bioquest Corp (BQST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Quarterly

0 15K 30K 45K Q1 '13: 0 Q2 '13: 0 Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 29.8K Q3 '15: 1.2K Q1 '13 Q3 '13 Q1 '14 Q3 '14 Q1 '15 Q3 '15

Gross Profit Quarterly

-150K -100K -50K 0 50K 100K 150K Q2 '14: 0 Q3 '14: 0 Q2 '15: -139.8K Q3 '15: -19.3K Q2 '14 Q3 '14 Q2 '15 Q3 '15

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q4 '13: -2.4K Q1 '14: -5K Q2 '14: -3.3K Q3 '14: -1.2K Q4 '14: -114.2K Q2 '15: -890K Q3 '15: -901K Q1 '20: -16.5K Q2 '20: -11.7K Q3 '20: -194.8K Q4 '20: -133.6K Q1 '21: -321.6K Q2 '21: -629.2K Q3 '21: -564.6K Q4 '21: -685.1K Q1 '22: -464.1K Q2 '22: -176.6K Q3 '22: 52.7K Q4 '22: -229.9K Q1 '23: -49.7K Q1 '14 Q4 '14 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23

Net Income Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q1 '14: -5K Q2 '14: -3.3K Q3 '14: 286 Q4 '14: -480K Q1 '15: -1.1M Q2 '15: -892.2K Q3 '15: -900.2K Q1 '20: -18.2K Q2 '20: -11.7K Q3 '20: -194.8K Q4 '20: -134.4K Q1 '21: -322.2K Q2 '21: -630.3K Q3 '21: -667.3K Q4 '21: -704.2K Q1 '22: -437K Q2 '22: -187.9K Q3 '22: 50.1K Q4 '22: -246.1K Q1 '23: -123.4K Q2 '14 Q1 '15 Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23

Cost of Revenue Quarterly

0 60K 120K 180K Q2 '14: 0 Q3 '14: 0 Q2 '15: 169.6K Q3 '15: 20.5K Q2 '14 Q3 '14 Q2 '15 Q3 '15

Operating Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q3 '13: -2.2K Q4 '13: -2.2K Q1 '14: -4.9K Q2 '14: -3.1K Q3 '14: 448 Q4 '14: -464.6K Q1 '15: -363.8K Q2 '15: -525.3K Q3 '15: -875.3K Q3 '20: -58.3K Q4 '20: -39.6K Q1 '21: -97.5K Q2 '21: -47.6K Q3 '21: -43K Q4 '21: -5.1K Q1 '22: -62.5K Q2 '22: -1.9K Q3 '22: -702 Q4 '22: -51.6K Q1 '23: -18.6K Q4 '13 Q3 '14 Q2 '15 Q4 '20 Q3 '21 Q2 '22 Q1 '23

Free Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q3 '14: 448 Q3 '15: -875.3K Q3 '14 Q3 '15

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 4M 8M 12M Q3 '13: 4.6M Q3 '14: 5.4M Q1 '21: 8.1M Q2 '21: 8.2M Q3 '21: 8.3M Q1 '22: 8.8M Q2 '22: 9.4M Q3 '22: 11.6M Q1 '23: 11.3M Q3 '13 Q1 '21 Q3 '21 Q2 '22 Q1 '23

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: -0.01 Q1 '15: -0.03 Q2 '15: -0.04 Q3 '15: -0.05 Q4 '21: -0.28 Q1 '22: -0.29 Q2 '22: -0.23 Q3 '22: -0.15 Q4 '22: -0.09 Q1 '23: -0.05 Q1 '14 Q3 '14 Q1 '15 Q3 '15 Q1 '22 Q3 '22 Q1 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.